Open AccessA 12-MONTH, MULTICENTER, RANDOMIZED, ADAPTIVE DESIGN, OPEN-LABEL STUDY TO EVALUATE THE BENEFIT OF C2 HOUR MONITORING OF NEORAL ON SAFETY AND EFFICACY OUTCOMES IN DE NOVO CARDIAC TRANSPLANT RECIPIENTS RECEIVING BASILIXIMAB INDUCTION
Author(s) -
Marcelo Cantarovich,
Hilary A. Chaudri Ross,
José M. Arizón,
María Ángeles Ruiz Gómez,
Lynn Straatman,
Josefina Orús,
Jonathan G. Howlett,
Beatriz Díaz,
S Wang,
L A Pulpón,
Haissam Haddad,
Marta Crespo,
E. Lage,
Nicolás Manito
Publication year - 2004
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200407271-01123
Subject(s) - medicine , basiliximab , renal function , dosing , immunosuppression , randomized controlled trial , creatinine , heart transplantation , urology , concomitant , clinical endpoint , transplantation , gastroenterology , kidney transplantation